Literature DB >> 8306331

Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid.

M T Huang1, C T Ho, Z Y Wang, T Ferraro, Y R Lou, K Stauber, W Ma, C Georgiadis, J D Laskin, A H Conney.   

Abstract

A methanol extract of the leaves of the plant Rosmarinus officinalis L. (rosemary) was evaluated for its effects on tumor initiation and promotion in mouse skin. Application of rosemary to mouse skin inhibited the covalent binding of benzo(a)pyrene [B(a)P] to epidermal DNA and inhibited tumor initiation by B(a)P and 7,12-dimethylbenz[a]anthracene (DMBA). Topical application of 20 nmol B(a)P to the backs of mice once weekly for 10 weeks, followed 1 week later by promotion with 15 nmol 12-O-tetradecanoylphorbol-13-acetate (TPA) twice weekly for 21 weeks, resulted in the formation of 7.1 tumors per mouse. In a parallel group of animals that were treated topically with 1.2 or 3.6 mg of rosemary 5 min prior to each application of B(a)P, the number of tumors per mouse was decreased by 54 or 64%, respectively. Application of rosemary to mouse skin also inhibited TPA-induced ornithine decarboxylase activity, TPA-induced inflammation, arachidonic acid-induced inflammation, TPA-induced hyperplasia, and TPA-induced tumor promotion. Mice initiated with 200 nmol DMBA and promoted with 5 nmol TPA twice weekly for 19 weeks developed an average of 17.2 skin tumors per mouse. Treatment of the DMBA-initiated mice with 0.4, 1.2, or 3.6 mg of rosemary together with 5 nmol TPA twice weekly for 19 weeks inhibited the number of TPA-induced skin tumors per mouse by 40, 68, or 99%, respectively. Topical application of carnosol or ursolic acid isolated from rosemary inhibited TPA-induced ear inflammation, ornithine decarboxylase activity, and tumor promotion. Topical application of 1, 3, or 10 mumol carnosol together with 5 nmol TPA twice weekly for 20 weeks to the backs of mice previously initiated with DMBA inhibited the number of skin tumors per mouse by 38, 63, or 78%, respectively. Topical application of 0.1, 0.3, 1, or 2 mumol ursolic acid together with 5 nmol TPA twice weekly for 20 weeks to DMBA-initiated mice inhibited the number of tumors per mouse by 45-61%.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8306331

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  98 in total

1.  Disruption of androgen and estrogen receptor activity in prostate cancer by a novel dietary diterpene carnosol: implications for chemoprevention.

Authors:  Jeremy J Johnson; Deeba N Syed; Yewseok Suh; Chenelle R Heren; Mohammad Saleem; Imtiaz A Siddiqui; Hasan Mukhtar
Journal:  Cancer Prev Res (Phila)       Date:  2010-08-24

2.  The triterpenoid CDDO-Me delays murine acute graft-versus-host disease with the preservation of graft-versus-tumor effects after allogeneic bone marrow transplantation.

Authors:  Minghui Li; Kai Sun; Doug Redelman; Lisbeth A Welniak; William J Murphy
Journal:  Biol Blood Marrow Transplant       Date:  2010-03-23       Impact factor: 5.742

Review 3.  The role and place of medicinal plants in the strategies for disease prevention.

Authors:  Abayomi Sofowora; Eyitope Ogunbodede; Adedeji Onayade
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-08-12

4.  Plasma 1,8-cineole correlates with cognitive performance following exposure to rosemary essential oil aroma.

Authors:  Mark Moss; Lorraine Oliver
Journal:  Ther Adv Psychopharmacol       Date:  2012-06

5.  Anti-proliferative and pro-apoptotic effects of rosemary and constituent terpenoids in a model for the HER-2-enriched molecular subtype of clinical breast cancer.

Authors:  Nitin Telang
Journal:  Oncol Lett       Date:  2018-07-31       Impact factor: 2.967

6.  Role of ursolic acid chalcone, a synthetic analogue of ursolic acid, in inhibiting the properties of CD133(+) sphere-forming cells in liver stem cells.

Authors:  Rui-Xin Lin; Lu-Lu Gong; Li-Mei Fan; Zhong-Kai Zhao; Shu-Li Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

7.  The anti-leukemic effect of carnosic acid combined with adriamycin in a K562/A02/SCID leukemia mouse model.

Authors:  Lu-Qun Wang; Ran Wang; Xiang-Xin Li; Xiao-Ning Yu; Xue-Liang Chen; Hao Li
Journal:  Int J Clin Exp Med       Date:  2015-07-15

8.  Carnosol, a dietary diterpene, displays growth inhibitory effects in human prostate cancer PC3 cells leading to G2-phase cell cycle arrest and targets the 5'-AMP-activated protein kinase (AMPK) pathway.

Authors:  Jeremy J Johnson; Deeba N Syed; Chenelle R Heren; Yewseok Suh; Vaqar M Adhami; Hasan Mukhtar
Journal:  Pharm Res       Date:  2008-02-21       Impact factor: 4.200

9.  Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR.

Authors:  Dorrah Deeb; Xiaohua Gao; Hao Jiang; Scott A Dulchavsky; Subhash C Gautam
Journal:  Prostate       Date:  2009-06-01       Impact factor: 4.104

10.  Synthesis of oxygenated oleanolic and ursolic acid derivatives with anti-inflammatory properties.

Authors:  Andrew T Nelson; Andrew M Camelio; Karin R Claussen; Jiyoon Cho; Lisa Tremmel; John DiGiovanni; Dionicio Siegel
Journal:  Bioorg Med Chem Lett       Date:  2015-07-22       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.